A review of the use of ketamine in pain management

Journal of Opioid Management

Volumn 9, Issue 5, 2013, Pages 379-388

  Tawfic, Qutaiba A ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Ketamine; Pain; Review

Indexed keywords

KETAMINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLACEBO;

ANALGESIA; CANCER PAIN; CHEMICAL STRUCTURE; CHRONIC PAIN; CLINICAL TRIAL (TOPIC); CONTINUOUS INFUSION; CYSTITIS; DISSOCIATIVE DISORDER; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DRUG SYNTHESIS; HUMAN; LIVER TOXICITY; LOW DRUG DOSE; LOWER URINARY TRACT SYMPTOM; PAIN; PAIN ASSESSMENT; PHARMACODYNAMICS; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; PSYCHOSIS; REVIEW; SICKLE CELL ANEMIA; VESICOURETERAL REFLUX; VISUAL HALLUCINATION;

EID: 84891330864     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2013.0180     Document Type: Review

References (76)

1. Oliveira CM, Sakata RK, Issy AM, et al.: Ketamine and pre-emptive analgesia. Rev Bras Anestesiol. 2004; 54: 739-752.
2. Corssen G, Domino EF: Dissociative anesthesia: Further pharmacologic studies and first clinical experience with the phencyclidine derivative CI-581. Anesth Analg. 1966; 45: 29-40.
3. Aroni F, Iacovidou N, Dontas I, et al.: Pharmacological aspects and potential new clinical applications of ketamine: Reevaluation of an old drug. J Clin Pharmacol. 2009; 49: 957-964.
4. Morgan CJ, Curran HV; Independent Scientific Committee on Drugs: Ketamine use: A review. Addiction. 2012; 107: 27-38.
5. Mathew SJ, Shah A, Lapidus K, et al.: Ketamine for treatment-resistant unipolar depression: Current evidence. CNS Drugs. 2012; 26: 189-204.
6. Benitez-Rosario MA, Feria M, Salinas-Martin A, et al.: A retrospective comparison of the dose ratio between subcutaneous and oral ketamine. J Pain Symptom Manage. 2003; 25: 400-402. (Pubitemid 36506665)
7. Ryu HG, Lee CJ, Kim YT, et al.: Preemptive low-dose epidural ketamine for preventing chronic postthoracotomy pain: A prospective, double-blinded, randomized, clinical trial. Clin J Pain. 2011; 27: 304-308.
8. Barros GA, Miot HA, Braz AM, et al.: Topical (S)-ketamine for pain management of postherpetic neuralgia. An Bras Dermatol. 2012; 87: 504-505.
9. Chong C, Schug SA, Page-Sharp M, et al.: Development of a sublingual/oral formulation of ketamine for use in neuropathic pain: Preliminary findings from a three-way randomized, crossover study. Clin Drug Investig. 2009; 29: 317-324.
10. Weber F, Wulf H, Gruber M, et al.: S-ketamine and S-norketamine plasma concentrations after nasal and i.v. administration in anesthetized children. Paediatr Anaesth. 2004; 14: 983-988. (Pubitemid 40023682)
11. Reich DL, Silvay G: Ketamine: An update on the first twenty-five years of clinical experience. Can J Anaesth. 1989; 36: 186-197. (Pubitemid 19110402)
12. Prommer EE: Ketamine for pain: An update of uses in palliative care. J Palliat Med. 2012; 15: 474-483.
13. Bhutta AT: Ketamine: a controversial drug for neonates. Semin Perinatol. 2007; 31: 303-308.
14. Visser E, Schug SA: The role of ketamine in pain management. Biomed Pharmacother. 2006; 60: 341-348.
15. Zempsky WT, Loiselle KA, Corsi JM, et al.: Use of low-dose ketamine infusion for pediatric patients with sickle cell disease-related pain: A case series. Clin J Pain. 2010; 26: 163-167.
16. De Kock MF, Lavand'homme PM: The clinical role of NMDA receptor antagonists for the treatment of postoperative pain. Best Pract Res Clin Anaesthesiol. 2007; 21: 85-98. (Pubitemid 46478028)
17. Neri CM, Pestieau SR, Darbari DS: Low-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell disease. Paediatr Anaesth. 2013; 23: 684-689.
18. Nagdeve NG, Yaddanapudi S, Pandav SS: The effect of different doses of ketamine on intraocular pressure in anesthetized children. J Pediatr Ophthalmol Strabismus. 2006; 43: 219-223. (Pubitemid 44204718)
19. Drayna PC, Estrada C, Wang W, et al.: Ketamine sedation is not associated with clinically meaningful elevation of intraocular pressure. Am J Emerg Med. 2012; 30: 1215-1218.
20. Nishimura M, Sato K: Ketamine stereoselectively inhibits rat dopamine transporter. Neurosci Lett. 1999; 274: 131-134. (Pubitemid 29457457)
21. Schwartzman RJ, Alexander GM, Grothusen JR: The use of ketamine in complex regional pain syndrome: Possible mechanisms. Expert Rev Neurother. 2011; 11: 719-734.
22. Kronenberg RH: Ketamine as an analgesic. J Pain Palliat Care Pharmacother. 2002; 16: 27-35.
23. Craven R: Ketamine. Anaesthesia. 2007; 62: 48-53.
24. Waxman K, Shoemaker WC, Lippmann M: Cardiovascular effects of anesthetic induction with ketamine. Anesth Analg. 1980; 59: 355-358. (Pubitemid 10102693)
25. Muir WW III, Hubbell JA: Cardiopulmonary and anesthetic effects of ketamine and its enantiomers in dogs. Am J Vet Res. 1988; 49: 530-534.
26. Mikesell CE, Atkinson DE, Rachman BR: Prolonged QT syndrome and sedation: A case report and a review of the literature. Pediatr Emerg Care. 2011; 27: 129-131.
27. Lau TT, Zed PJ: Does ketamine have a role in managing severe exacerbation of asthma in adults? Pharmacotherapy. 2001; 21: 1100-1106. (Pubitemid 32807870)
28. Lipton SA: Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond. Nat Rev Drug Discov. 2006; 5: 160-170.
29. Wollmuth LP, Sobolevsky AI: Structure and gating of the glutamate receptor ion channel. Trends Neurosci. 2004; 27: 321-328. (Pubitemid 38692413)
30. Rodríguez-Muñoz M, Sánchez-Blázquez P, Vicente-Sánchez A, et al.: The mu-opioid receptor and the NMDA receptor associate in PAG neurons: Implications in pain control. Neuropsychopharmacology. 2012; 37: 338-349.
31. Orser BA, Pennefather PS, MacDonald JF: Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology. 1997; 86: 903-917. (Pubitemid 27174731)
32. Thomson AM, Girdlestone D, West DC: A local circuit neocortical synapse that operates via both NMDA and non-NMDA receptors. Br J Pharmacol. 1989; 96: 406-408. (Pubitemid 19045116)
33. Raha S, Gadgil P, Sankhla C, et al.: Nonparaneoplastic anti-N-methyl-D-aspartate receptor encephalitis: A case series of four children. Pediatr Neurol. 2012; 46: 246-249.
34. Dalmau J, Gleichman AJ, Hughes EG, et al.: Anti-NMDA-receptor encephalitis: Case series and analysis of the effects of antibodies. Lancet Neurol. 2008; 7: 1091-1098.
35. Chen HS, Lipton SA: The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem. 2006; 97: 1611-1626.
36. Bell RF, Dahl JB, Moore RA, et al.: Perioperative ketamine for acute postoperative pain. Cochrane Database Syst Rev. 2010: CD004603.
37. Honarmand A, Safavi M, Karaky H: Preincisional administration of intravenous or subcutaneous infiltration of low-dose ketamine suppresses postoperative pain after appendectomy. J Pain Res. 2012; 5: 1-6.
38. Laskowski K, Stirling A, McKay WP, et al.: A systematic review of intravenous ketamine for postoperative analgesia. Can J Anaesth. 2011; 58: 911-923.
39. Mathews TJ, Churchhouse AM, Housden T, et al.: Does adding ketamine to morphine patient-controlled analgesia safely improve post-thoracotomy pain? Interact Cardiovasc Thorac Surg. 2012; 14: 194-199.
40. Carstensen M, Møller AM: Adding ketamine to morphine for intravenous patient-controlled analgesia for acute postoperative pain: A qualitative review of randomized trials. Br J Anaesth. 2010; 104: 401-406.
41. Urban MK, Ya Deau JT, Wukovits B, et al.: Ketamine as an adjunct to postoperative pain management in opioid tolerant patients after spinal fusions: A prospective randomized trial. HSS J. 2008; 4: 62-65.
42. Angst MS, Clark JD: Ketamine for managing perioperative pain in opioid-dependent patients with chronic pain - A unique indication? Anesthesiology. 2010; 113: 514-515.
43. Hocking G, Visser EJ, Schug SA: Ketamine: Does life begin at 40? Pain: Clin Updates (IASP). 2007; 15: 1-6.
44. Loftus RW, Yeager MP, Clark JA, et al.: Intraoperative ketamine reduces perioperative opiate consumption in opiate-dependent patients with chronic back pain undergoing back surgery. Anesthesiology. 2010; 113: 639-646.
45. Joly V, Richebe P, Guignard B, et al.: Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology. 2005; 10: 147-155. (Pubitemid 40943147)
46. Chazan S, Ekstein MP, Marouani N, et al.: Ketamine for acute and subacute pain in opioid-tolerant patients. J Opioid Manag. 2008; 4: 173-180.
47. Elia N, Tramér MR. Ketamine and postoperative pain - A quantitative systematic review of randomised trials. Pain. 2005; 113: 61-70. (Pubitemid 40044753)
48. Dahmani S, Michelet D, Abback PS, et al.: Ketamine for peri-operative pain management in children: A meta-analysis of published studies. Paediatr Anaesth. 2011; 21: 636-652.
49. Min TJ, Kim WY, Jeong WJ, et al.: Effect of ketamine on intravenous patient-controlled analgesia using hydromorphone and ketorolac after the Nuss surgery in pediatric patients. Korean J Anesthesiol. 2012; 62: 142-147.
50. Ben-Ari A, Lewis MC, Davidson E.: Chronic administration of ketamine for analgesia. J Pain Palliat Care Pharmacother. 2007; 21: 7-14. (Pubitemid 46607874)
51. Bell RF: Ketamine for chronic non-cancer pain. Pain. 2009; 141: 210-214.
52. Noppers I, Niesters M, Aarts L, et al.: Ketamine for the treatment of chronic non-cancer pain. Expert Opin Pharmacother. 2010; 11: 2417-2429.
53. Soto E, Stewart DR, Mannes AJ, et al.: Oral ketamine in the palliative care setting: A review of the literature and case report of a patient with neurofibromatosis type 1 and glomus tumor-associated complex regional pain syndrome. Am J Hosp Palliat Care. 2012; 29: 308-317.
54. Hocking G, Cousins MJ. Ketamine in chronic pain management: An evidence based review. Anesth Analg. 2003; 97: 1730-1739. (Pubitemid 37475130)
55. Okon T: Ketamine: An introduction for the pain and palliative medicine physician. Pain Physician. 2007; 10: 493-500.
56. Mahoney JM, Vardaxis V, Moore JL, et al.: Topical ketamine cream in the treatment of painful diabetic neuropathy: A randomized, placebo-controlled, double-blind initial study. Pain J Am Podiatr Med Assoc. 2012; 102: 178-183.
57. Finch PM, Knudsen L, Drummond PD: Reduction of allodynia in patients with complex regional pain syndrome: A double-blind placebo-controlled trial of topical ketamine. Pain. 2009; 146: 18-25.
58. Hackworth RJ, Tokarz KA, Fowler IM, et al.: Profound pain reduction after induction of memantine treatment in two patients with severe phantom limb pain. Anesth Analg. 2008; 107: 1377-1379.
59. Grande LA, O'Donnell BR, Fitzgibbon DR, et al.: Ultra-low dose ketamine and memantine treatment for pain in an opioid-tolerant oncology patient. Anesth Analg. 2008; 107: 1380-1383.
60. Bell RF, Eccleston C, Kalso EA: Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev. 2003; 1: CD003351.
61. Kannan TR, Saxena A, Bhatnagar S, et al.: Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients. J Pain Symptom Manage. 2002; 23: 60-65. (Pubitemid 34093884)
62. Salas S, Frasca M, Planchet-Barraud B, et al.: Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: Considerations about the clinical research in palliative care. J Palliat Med. 2012; 15: 287-293.
63. Chen CH, Lee MH, Chen YC, et al.: Ketamine-snorting associated cystitis. J Formos Med Assoc. 2011; 110: 787-791.
64. Schönenberg M, Reichwald U, Domes G, et al.: Effects of peritraumatic ketamine medication on early and sustained posttraumatic stress symptoms in moderately injured accident victims. Psychopharmacology. 2005; 182: 420-425. (Pubitemid 41464654)
65. Morgan CJ, Muetzelfeldt L, Curran HV: Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: A 1-year longitudinal study. Addiction. 2010; 105: 121-133.
66. Javitt DC: Glutamatergic theories of schizophrenia. Isr J Psychiatry Relat Sci. 2010; 47: 4-16.
67. Covvey JR, Crawford AN, Lowe DK: Intravenous ketamine for treatment-resistant major depressive disorder. Ann Pharmacother. 2012; 46: 117-123.
68. Wood D, Cottrell A, Baker SC, et al.: Recreational ketamine: From pleasure to pain. BJU Int. 2011; 107: 1881-1884.
69. Middela S, Pearce I: Ketamine-induced vesicopathy: A literature review. Int J Clin Pract. 2011; 65: 27-30.
70. Chu PS, Ma WK, Wong SC, et al.: The destruction of the lower urinary tract by ketamine abuse: A new syndrome? BJU Int. 2008; 102: 1616-1622.
71. Bell RF: Ketamine for chronic noncancer pain: Concerns regarding toxicity. Curr Opin Support Palliat Care. 2012; 6: 183-187.
72. Seto WK, Ng M, Chan P, et al.: Ketamine-induced cholangiopathy: A case report. Am J Gastroenterol. 2011; 106: 1004-1005.
73. Sear JW: Ketamine hepato-toxicity in chronic pain management: Another example of unexpected toxicity or a predicted result from previous clinical and pre-clinical data? Pain. 2011; 152: 1946-1947.
74. Wai M, Chan W, Zhang A, et al.: Long-term ketamine and ketamine plus alcohol treatments produced damages in liver and kidney. Hum Exp Toxicol. 2012; 31: 877-886.
75. Chan WM, Xu J, Fan M, et al.: Downregulation in the human and mice cerebella after ketamine versus ketamine plus ethanol treatment. Microsc Res Tech. 2012; 75: 258-264.
76. Chan WM, Liang Y, Wai MS, et al.: Cardiotoxicity induced in mice by long term ketamine and ketamine plus alcohol treatment. Toxicol Lett. 2011; 207: 191-196.